BNCT

RADIATION4 trials

Sponsors

Kawasaki Medical School, Boneca Corporation, Stella Pharma Corporation

Conditions

Head and Neck CancerThoracic Solid Malignant TumorUnresectable Angiosarcomamalignant skin tumors

Phase 1

Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck Cancer

TerminatedNCT00927147

Boneca CorporationHead and Neck Cancer

Start: 2009-06-30End: 2013-06-30Updated: 2017-01-31

Using CICS-1 and SPM-011 and ［18F］FBPA Commissioned by CICS and Sumitomo Heavy Industries and STELLA PHARMA

Enrolling by invitationNCT06603987

Stella Pharma CorporationThoracic Solid Malignant Tumor

Start: 2025-04-10End: 2028-10-31Target: 30Updated: 2025-11-19

Phase 2

A Phase II Study by Using CICS-1 and SPM-011 Commissioned by CICS and STELLA PHARMA

Active, not recruitingNCT05601232

Stella Pharma CorporationUnresectable Angiosarcoma

Start: 2022-11-01End: 2025-08-31Target: 10Updated: 2025-04-09

Unknown Phase

BNCT clinical trial for malignant skin tumors

Active, not recruitingJPRN-UMIN000013101

Kawasaki Medical Schoolmalignant skin tumors

Start: 2014-03-01Target: 20Updated: 2026-06-29